Vaxcyte, Inc.PCVXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P44
Within normal range
vs 5Y Ago
-11.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025-15.82%
Q3 2025-27.77%
Q2 2025-18.37%
Q1 2025-2.65%
Q4 2024-32.93%
Q3 202419.87%
Q2 2024-35.45%
Q1 202447.44%
Q4 2023-95.11%
Q3 2023-35.59%
Q2 2023-13.03%
Q1 202322.53%
Q4 2022-34.76%
Q3 2022-19.34%
Q2 2022-24.49%
Q1 2022-36.49%
Q4 2021-7.32%
Q3 2021-12.40%
Q2 2021-11.59%
Q1 2021-2.33%
Q4 20201.34%
Q3 2020-3.44%
Q2 202025.13%
Q1 2020-52.33%
Q4 2019-57.44%
Q3 2019-6.11%
Q2 201921.99%
Q1 20190.00%